Can chitotriosidase be a surrogate marker for invasive fungal disease?

J Mycol Med. 2012 Sep;22(3):256-60. doi: 10.1016/j.mycmed.2012.07.049. Epub 2012 Aug 14.

Abstract

Background: Chitotriosidase (CHT) enzyme has been known to be secreted from the activated macrophages. We infer with these data that CHT activity is an indicator for the defence.

Methods: In this study, we evaluated CHT levels in both neutropenic and non neutropenic patients. CHT enzyme activity was measured and compared to each other groups.

Results: Chitotriosidase levels were found to be significantly higher in neutropenic patients with candidemia.

Conclusion: In the comparison between neutropenic and non neutropenic patients, there was a significant difference for CHT levels. The use of this enzyme as a surrogate marker for candidemias were evaluated in neutropenic and non neutropenic patients.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bacteremia / blood
  • Bacteremia / complications
  • Biomarkers
  • Candidemia / blood*
  • Candidemia / complications
  • Candidemia / enzymology
  • Candidemia / immunology
  • Coinfection
  • Female
  • Fungal Proteins / blood*
  • Hexosaminidases / blood*
  • Humans
  • Immunocompromised Host
  • Leukocyte Count
  • Male
  • Middle Aged
  • Neoplasms / blood
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neutropenia / blood
  • Neutropenia / chemically induced
  • Predictive Value of Tests
  • Young Adult

Substances

  • Biomarkers
  • Fungal Proteins
  • Hexosaminidases
  • chitotriosidase